Clinical Trial Update: Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial [Phase 4]

View source ↗

Summary

A Phase 4 open-label trial evaluated dupilumab in adolescent and adult participants with moderate-to-severe atopic dermatitis in skin of color. The study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Moderate-to-Severe Atopic Dermatitis, Atopic Eczema | Phase 4 | Status: COMPLETED | Results posted: 2026-01-02